ACM Global Central Lab Executive to Present at Outsourcing in Clinical Trials New England

VP of Clinical Trials Offers Insight on Building Strategic Relationships with Central Labs to Optimize Operations and Logistical Efficiencies

Rochester, NY, Sept. 27, 2011 – ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, today announced that it will feature Vice President, Clinical Trials Tracy Hendershott as a speaker at this year’s Outsourcing in Clinical Trials New England in Boston from Sept. 28-29, 2011.

Hendershott, a seasoned executive with twenty years of clinical trial experience, will present a case study on “Demonstrating the value of moving away from a transactional relationship with your central lab to optimize operations and logistical efficiencies.” The case study will explore best practices for building robust strategic relationships with central labs, including:
  • Streamlining the collection process to PK labs to reduce the time it takes to complete your data lock allowing you to meet targets and lower costs;
  • Consolidating specimen collection and shipping and creating a single point of contact to accelerate the data cleaning process;
  • Creating strong ties to your central lab to efficiently facilitate the work order through a common understanding of data formats throughout the lifecycle of your study;
  • Deploying periodic shipments to sub-vendors to eliminate duplicate shipments to sites to elevate user-friendliness and save money in reduced shipping;
  • Introducing esoteric assays which stay volume-driven by protocols across the study program to allow you to meet study-specific deadlines.
Hendershott’s presentation will be held on Wednesday, Sept. 28th at 3:00 p.m.

To meet with ACM Global Central Lab at Outsourcing in Clinical Trials New England or for more information, please visit the website.

About ACM Global Central Lab
ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s services extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting.

For more information, visit www.acmgloballab.com and our Central Labs in Focus blog at www.acmgloballab.com/blog.

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement